AC
HSTO

Armistice Capital’s Histogen Inc. Common Stock HSTO Stock Holding History

Armistice Capital’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-247,059
Closed -$1.64M – 201
2021
Q4 		$1.64M Buy
+247,059
New +$2.83M 0.03% 125

Other funds holding HSTO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Armistice Capital's HSTO Position: Q1 2022 in Review

Armistice Capital sold out of Histogen Inc. Common Stock (HSTO) in Q1 2022, closing a stake of 247,059 shares — an estimated $1.64M sold.

Armistice Capital first reported a position in HSTO in Q4 2021 and held it in 1 quarter. The position peaked at $1.64M in Q4 2021. 22 funds tracked by Wall St. Rank hold HSTO as of Q1 2022.

  • Armistice Capital reported no remaining Histogen Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Armistice Capital sold 247,059 Histogen Inc. Common Stock shares in Q1 2022, an estimated $1.64M.
  • Armistice Capital first reported a position in Histogen Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Armistice Capital's Histogen Inc. Common Stock position peaked at $1.64M in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2022.

Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.